| DC Field | Value | Language |
|---|
| dc.contributor.author | Khmelnitskiy, R. A. | - |
| dc.contributor.author | Vislobokov, A. V. | - |
| dc.date.accessioned | 2022-05-04T13:46:51Z | - |
| dc.date.available | 2022-05-04T13:46:51Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Khmelnitskiy, R.A. Clinical feasibility study of an immunotropic drug for treatment of complicated pyodermas / R.A. Khmelnitskiy, A.V. Vislobokov // Research Results in Pharmacology. - 2020. - Vol.6, №3.-P. 51-57. - Doi: 10.3897/rrpharmacology.6.50797. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46590 | - |
| dc.description.abstract | The aim of the study was to evaluate the clinical and economic effectiveness of immunocorrection in severe and chronic forms of pyoderma with drugs from different pharmacological groups | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | antimicrobial activity | ru |
| dc.subject | conditionally pathogenic microorganisms | ru |
| dc.subject | cyclic aminoindoles | ru |
| dc.subject | non-cyclic aminoindoles | ru |
| dc.subject | pyrroloquinolones | ru |
| dc.title | Clinical feasibility study of an immunotropic drug for treatment of complicated pyodermas | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 6, № 3
|
